No profile data available.
Celldex Therapeutics, Inc. (CLDX) is a healthcare company in the various production contracting industry, based in Hampton, United States, with about 198 full-time employees.
It reported revenue of $1.55 million for fiscal year 2025, down 78.0% from fiscal year 2024, and net income of -$258.76 million. Its market capitalization was $2.35 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate.
Celldex Therapeutics reported $1.55 million in revenue for fiscal year 2025, down 78.0% from $7.02 million in fiscal year 2024.
$2.35 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (various production contracting) include Sotera Health Company (SHC).